Merck has become inexpensive again and combines a good growth outlook with a nice and growing dividend. Learn why MRK stock ...

(RTTNews) - Merck & Co Inc. (MRK), Monday said China's National Medical Products Administration (NMPA) has approved Keytruda in combination with chemo therapy as neoadjuvant treatment, then as ...

We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Shares of Merck & Co. Inc. MRK inched 0.74% higher to $102.00 Friday, on what proved to be an all-around mixed trading ...

We recently published a list of 11 Best Beginner Stocks To Invest In Now. In this article, we are going to take a look at ...

Merck & Co. Inc. closed $33.63 below its 52-week high ($134.63), which the company achieved on June 25th.

Merck & Co – known as MSD outside of the US and Canada – has shared positive results from a late-stage trial of a Keytruda ...

We recently published a list of 12 Best Affordable Stocks To Buy Right Now. In this article, we are going to take a look at ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate, trumpeting a 100% complete response rate but ...

Deep-pocketed investors have adopted a bearish approach towards Merck & Co MRK, and it's something market players shouldn't ...

AstraZeneca Plc (NASDAQ:AZN) and Merck & Co Inc (NYSE:MRK), on Wednesday, announced long-term results from the OlympiA Phase 3 trial. The trial showed Lynparza (olaparib) demonstrated sustained ...

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...